Kim Ritchey

2.1k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Kim Ritchey is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Kim Ritchey has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in Kim Ritchey's work include Acute Lymphoblastic Leukemia research (5 papers), Hemoglobinopathies and Related Disorders (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Kim Ritchey is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Hemoglobinopathies and Related Disorders (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Kim Ritchey collaborates with scholars based in United States, Switzerland and Canada. Kim Ritchey's co-authors include Jeffrey S. Lobel, Harold S. Zarkowsky, Marilyn Gaston, Frances M. Gill, Charles H. Pegelow, John F. Kelleher, Steven Diamond, Joel Verter, C. Tate Holbrook and Gerald M. Woods and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Kim Ritchey

8 papers receiving 1.1k citations

Hit Papers

Prophylaxis with Oral Penicillin in Children with Sickle ... 1986 2026 1999 2012 1986 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Ritchey United States 8 762 749 420 255 116 8 1.2k
F. Albertini Italy 9 855 1.1× 815 1.1× 386 0.9× 117 0.5× 68 0.6× 12 1.2k
Paola Polchi Italy 16 1.5k 2.0× 1.5k 1.9× 543 1.3× 184 0.7× 131 1.1× 21 2.0k
Rachel B. Salit United States 16 717 0.9× 293 0.4× 151 0.4× 199 0.8× 251 2.2× 67 1.0k
Raffaella Colombatti Italy 19 469 0.6× 592 0.8× 266 0.6× 37 0.1× 90 0.8× 79 1.1k
G. Socié France 13 552 0.7× 188 0.3× 123 0.3× 155 0.6× 205 1.8× 20 954
Karima Yakouben France 19 459 0.6× 119 0.2× 218 0.5× 265 1.0× 172 1.5× 50 893
Juan Wu United States 17 1.1k 1.5× 171 0.2× 193 0.5× 315 1.2× 431 3.7× 52 1.5k
Glen Kennedy Australia 21 483 0.6× 217 0.3× 154 0.4× 174 0.7× 385 3.3× 115 1.4k
Gerald Presbury United States 9 646 0.8× 755 1.0× 335 0.8× 46 0.2× 26 0.2× 13 1.1k
Betty K. Hamilton United States 20 851 1.1× 209 0.3× 214 0.5× 314 1.2× 485 4.2× 163 1.4k

Countries citing papers authored by Kim Ritchey

Since Specialization
Citations

This map shows the geographic impact of Kim Ritchey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Ritchey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Ritchey more than expected).

Fields of papers citing papers by Kim Ritchey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Ritchey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Ritchey. The network helps show where Kim Ritchey may publish in the future.

Co-authorship network of co-authors of Kim Ritchey

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Ritchey. A scholar is included among the top collaborators of Kim Ritchey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Ritchey. Kim Ritchey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chen, Yanjun, Lindsey Hageman, Anne Angiolillo, et al.. (2023). Poverty and Relapse Risk in Children with Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL03N1 Report. Blood. 142(3). 221–229. 10 indexed citations
2.
Turner, Rose, Abrahim I. Orabi, Craig A. Byersdorfer, et al.. (2017). Risk Factors for Asparaginase-associated Pancreatitis. Journal of Clinical Gastroenterology. 51(10). 907–913. 33 indexed citations
3.
Barredo, Julio C., Caroline A. Hastings, Meenakshi Devidas, et al.. (2017). Isolated late testicular relapse of B‐cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response‐based testicular radiation: A Children's Oncology Group study. Pediatric Blood & Cancer. 65(5). e26928–e26928. 26 indexed citations
4.
Jeha, Sima, Bassem I. Razzouk, Michael Rytting, et al.. (2009). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia. Journal of Clinical Oncology. 27(26). 4392–4397. 58 indexed citations
5.
Jeha, Sima, Paul S. Gaynon, Bassem I. Razzouk, et al.. (2006). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 24(12). 1917–1923. 215 indexed citations
6.
Gaston, Marilyn, Joel Verter, Gerald M. Woods, et al.. (1989). Prophylaxis With Oral Penicillin in Children With Sickle Cell Anemia: A Randomized Trial. PEDIATRICS. 83(5). 835–835. 42 indexed citations
7.
Gaston, Marilyn, Joel Verter, Gerald M. Woods, et al.. (1986). Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia. New England Journal of Medicine. 314(25). 1593–1599. 820 indexed citations breakdown →
8.
Ritchey, Kim, et al.. (1985). Heterogeneity of erythropoietin‐dependent erythrocytosis: case report in a child and synopsis of primary erythrocytosis syndromes. British Journal of Haematology. 60(4). 751–758. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026